FibroBiologics to Provide Company Update at Upcoming Conferences
HOUSTON, September 14, 2023/PRNewswire/ – FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and